Search results
- 4.3800Add to watchlist-0.0300 (-0.68%)At close:4:00 PM EDTTue. Jul 16, 20244.3200 -0.06 (-1.37%)After hrs:5:26 PM EDTTue. Jul 16, 2024Nasdaq Real Time Price (USD) · Market closed
- Open4.4100High4.6000Low4.3666
- Mkt Cap3.66MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close4.410052 Wk. Low3.410052 Wk. High90.6500
Related stocks
Find the latest ZyVersa Therapeutics, Inc. (ZVSA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Jul 5, 2024 · ZVSA is the ticker symbol for ZyVersa Therapeutics Inc., a biotechnology company developing treatments for inflammatory and metabolic diseases. See the latest stock price, performance, analyst ratings, news and press releases for ZVSA on MarketWatch.
- 25.05%
- 0.56%
- 51.58%
- 60.78%
4 days ago · Should You Buy or Sell ZyVersa Therapeutics Stock? Get The Latest ZVSA Stock Analysis, Price Target, Headlines, and Short Interest at MarketBeat.
- kcashmere@zyversa.com
- (754) 231-1688
- 7
Jul 6, 2024 · Stock analysis for ZyVersa Therapeutics Inc (ZVSA:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Get the latest Zyversa Therapeutics Inc (ZVSA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Jul 5, 2024 · A high-level overview of ZyVersa Therapeutics, Inc. (ZVSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
People also ask
What is zyversa Therapeutics (zvsa) stock price?
Does zvsa have company insights?
Where can I buy zvsa stock?
Where is zyversa Therapeutics (zvsa) headquartered?
6 days ago · ZyVersa is a biopharmaceutical company developing drugs for inflammatory diseases. See its latest financial results, clinical trials, news and stock performance on Stock Analysis.